Getting to the Heart of the Matter: Medscape Education at AHA 2024!
November 12, 2024 | AHA24, CME, Cardiovascular, Symposia, cardiology, cardiomyopathy, hypertension
Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November 16-18 — a dynamic event packed with cutting-edge cardiology education that you won’t want to miss! 🚀 This year, we are hosting 6 highly interactive symposia, each designed to elevate the learner’s expertise and knowledge, while diving deep into the latest advancements in Cardiology!
Key Symposia at AHA 2024
Our carefully curated symposia cover a broad range of critical cardiology topics, ensuring that attendees are well-equipped to tackle emerging challenges in cardiovascular health. Here’s a preview of what you can expect:
Saturday, November 16
1. Proactive Cardiovascular Protection Along the Cardiac Continuum: Understanding Risk to Optimize Prevention: Explore cutting-edge strategies in proactive cardiovascular protection. By understanding the full spectrum of cardiovascular risk, we can improve prevention efforts and outcomes.
2. Navigating New Paradigms in Thrombosis Management: Gameshow Evaluation of Evolving Anticoagulation Approaches: This interactive “gameshow” format, is designed to engage learners in the latest advancements in anticoagulation therapies and their role in thrombosis management.
Sunday, November 17
3. From Challenge to Control: Innovative Therapies in Hypertension Management: Discover the recent innovations in the treatment of hypertension, including novel therapies and management strategies aimed at overcoming the challenges faced by clinicians.
4. Transforming Perspectives on Transthyretin Amyloid Cardiomyopathy: Insights Into Evolving Advances: Learn about recent advances in diagnostics and treatment options for Transthyretin amyloid cardiomyopathy.
5. Heart Failure with Preserved or Mildly Reduced Ejection Fraction: Impacting Health Outcomes with Nonsteroidal MRAs: Explore how the use of nonsteroidal mineralocorticoid receptor antagonists (MRAs) can improve outcomes in patients with heart failure, particularly those with preserved or mildly reduced ejection fraction.
6. Hypertrophic Cardiomyopathy Masterclass: Rapid Fire Case Consults: In this hands-on masterclass, we will work through real-life hypertrophic cardiomyopathy (HCM) cases, providing expert insights and interactive discussions on the latest diagnostic and therapeutic approaches.
These sessions are more than just symposia— they offer an opportunity to engage with leading cardiology experts, participate in thought-provoking discussions, and gain insights that can immediately enhance clinical practice. Don’t miss this chance to take your cardiology practice to the next level. Register today and secure your spot for these educational opportunities!
Additionally, be sure to join us for a highly anticipated oral presentation on “Echocardiography in Hypertrophic Cardiomyopathy: Virtual CME Advances Physician Knowledge and Confidence,” November 18th from 9:40 am – 9:45 am, during the Imaging and Technologies in Heart Failure digital poster session.
For more information on Cardiology Education, contact David Anderson.
We look forward to seeing you at AHA 2024 in Chicago, IL!
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Hear From Her: Extraordinary Women Who Are Redefining Healthcare Leadership
That’s a wrap for Season 2 of Medscape Education’s Award-Winning Podcast Series, Hear From Her: Women in Healthcare Leadership! (Not to worry, Season 3 is just around the corner.) And...
Bringing Clinicians Together for Oncology Education at ESMO 2024
ESMO 2024 comes with the debut of 2 new, exciting symposia hosted by the MedscapeLIVE! team. The symposia build on nearly 30 years of Medscape’s experience and excellence in both...
Empowering Women in Health Care Through Education
In a bold stride toward empowering women in health care, Medscape proudly announces its sponsorship of the highly anticipated Women in Medicine Summit, September 13-14, 2024 in Chicago, Illinois. This...
Leading the Way at ESC 2024
Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...
Always Be in a Growth Mindset: Chief Strategy Officer Christina Hoffman’s Return to Her Education Roots
Medicine is always changing, and the career of Medscape Education’s Chief Strategy Officer, Christina Hoffman, is no exception. The 17-year Medscape veteran recently said goodbye to her role as leader...
Medscape Education Showcases Unprecedented Achievements at EHA 2024
Medscape Education is proud to share its monumental success at the EHA 2024 Congress. Our continued commitment to patient-centric medical education was evident throughout the event, with notable achievements and...
Reaching Women Where They’re At: Setting Up a Safe Space for HIV Prevention Conversations
“I always enjoyed solving problems and putting puzzles together,” says Harmony Garges, MD, CMO at ViiV Healthcare and a pediatric infectious disease specialist. “So for me, infectious disease was a...
Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference
Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...
Stemming the Flow–Medscape Presents at HLTH Europe
Medscape Education will be attending HLTH Europe from June 17-20. Be sure to drop by our booth to participate in our survey and enjoy exciting giveaways. Additionally, Dr. John Whyte,...
Medscape Education to Emphasize the Role of Education in Digital Therapeutics at DTA Summit
As a leader in medical education and proud sponsor of the 2024 Digital Therapeutics Summit, Medscape is excited to announce that Medscape Education’s Chief Strategy Officer, Christina Hoffman, will be...